MedTech Careers provides career opportunities in the MedTech industry, focusing on the development of medical devices and solutions that impact healthcare.

MedTech Careers

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Maxwell Becton

Fairleigh Dickinson

Becton, Dickinson and Company

Change Healthcare Inc., an independent healthcare technology company, provides data and analytics-driven solutions to enhance clinical, financial, administrative, and patient engagement outcomes in the United States healthcare system. It operates through three segments: Software and Analytics, Network Solutions, and Technology-Enabled Services. The Software and Analytics segment offers software and analytics solutions for revenue cycle management, provider network management, payment accuracy, clinical decision support, value-based payment, consumer engagement, risk adjustment and quality performance, and imaging and clinical workflow. The Network Solutions segment provides solutions for financial, administrative, and clinical and pharmacy transactions; connected consumer health; network; electronic payments; data; pharmacy; and aggregation and analytics of clinical and financial data. The Technology-Enabled Services segment offers solutions for financial and administrative management, value-based care, communication and payment, pharmacy benefits administration, and healthcare consulting. The company serves commercial insurers, private insurers, BlueCross Blue Shield plans, Medicare/Medicaid plans, provider-sponsored payers, third party administrators, emerging technology and data-driven health plans, and other specialty health benefits insurers, as well as hospitals and health systems, physician practices, dentists, pharmacies, skilled nursing facilities, home health agencies, telehealth providers, senior care facilities, laboratories, and other healthcare providers. Change Healthcare Inc. was incorporated in 2016 and is headquartered in Nashville, Tennessee.

Robert Hendrick

Christopher Parks

Change Healthcare Inc.

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Metric
Company Name	MedTech Careers	Becton, Dickinson and Company	Change Healthcare Inc.	Coloplast A/S
Symbol		BDX	CHNG	COLO-B
MSH ID	DK:MEDTECHCAREERS	COM:BD	COM:CHANGEHEALTHCARE	COM:COLOPLAST
Market	PRIVATE	STOCKS	STOCKS	STOCKS
Sector	Commercial & Professional Services	Healthcare	Healthcare	Healthcare
Industry	Healthcare	Medical - Instruments & Supplies	Medical - Healthcare Information Services	Medical - Instruments & Supplies
Country	DK	US	US	DK
Stage
Employee Count		70K	14K	15.93K
Website	medtechcareers.dk	bd.com	changehealthcare.com	coloplast.com
LinkedIn		bd1	change-healthcare	coloplast
Founders

Metric
Market Cap	64.70B		27.06B
Enterprise Value
Monthly Web Traffic		295.49K	87.07K
Web Traffic Growth		-0.09	-0.17
Valuation
Raised Capital

Metric
Revenue	20.18B	3.48B	3.83B
Revenue (LTM)
Revenue (NTM)
Gross Profit	20.18B	1.85B	2.48B
EBITDA	2.42B	813.56M	1.21B
Operating Income	2.42B	128.24M	1.05B
Net Income	1.73B	-57.39M	715.45M
EPS	5.96	-0.18	3.18
Diluted EPS	5.93	-0.18	3.18
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.55	1	0.68
Operating Profit Margin	0.12	0.06	0.27
EBITDA Margin	0.12	0.23	0.32
Net Profit Margin	0.07	-0.04	0.19
Return on Equity	0.06	-0.05	0.42
Return on Assets	0.03	-0.02	0.10
Return on Capital Employed	0.05	0.03	0.23

MEDT

DK:MEDTECHCAREERS

MedTech Careers

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	54.49	-146.46	35.22
P/B Ratio	2.70	2.73	9.74
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.63		8.41
EV Multiple	15.21	-4.86	23.81

Metric
Days Sales Outstanding	42.45	145.16
Days Payables Outstanding			57.80
Days Inventory Outstanding	105.52		157.08
Operating Cycle	151.20		236.45
Cash Conversion Cycle	47.37		185.86
Asset Turnover	0.37	0.35	0.54

Metric
Operating Cash Flow	3.84B	696.88M	391.71M
Free Cash Flow	3.12B	420.60M	226.59M
Cash Flow to Debt	0.21	0.15	0.26
Operating Cash Flow/Sales	0.20	0.20	0.22
Free Cash Flow Yield	0.04		0.02

Metric
Cash & Equivalents	1.86B	252.30M	111.59M
Accounts Receivable		12.29M	-71.66M
Inventory	3.84B		520.02M
Goodwill	26.46B	4.11B	2.74B
Debt to Capitalization	0.43	0.59	0.59
Debt to Assets	0.33	0.47	0.41
Current Ratio	1.08	1.23	0.61
Quick Ratio	1.36	0.90	0.56

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01	0.08
R&D to Revenue	0.06	0.08	0.04
SG&A to Revenue			0.05